LCTX
Lineage Cell Therapeutics Inc
NYSE MKT: LCTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
-2.05% today
Updated 2026-05-06
Market cap
$363.98M
P/E ratio
—
P/S ratio
25.01x
EPS (TTM)
$-0.28
Dividend yield
—
52W range
$0 – $2
Volume
1.2M
Lineage Cell Therapeutics Inc (LCTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.96M | $650507.00 | $175102.00 | $1.04M | $13.43M | $53.27M | $45.83M | $29.75M | $57.73M | $74.90M | $94.66M | $142.57M | $173.24M | $101.66M | $125.48M | $107.95M | $174.54M | $123.66M | $101.02M | $113.22M |
| Cash & equivalents | $1.83M | $561017.00 | $9501.00 | $12279.00 | $12.19M | $33.32M | $22.21M | $4.35M | $5.50M | $29.49M | $42.23M | $22.09M | $36.84M | $23.59M | $9.50M | $32.59M | $55.74M | $11.36M | $35.44M | $45.79M |
| Current assets | $1.93M | $618692.00 | $141646.00 | $108874.00 | $12.37M | $35.57M | $24.96M | $7.18M | $7.95M | $32.40M | $47.24M | $25.65M | $42.62M | $36.36M | $57.52M | $44.00M | $111.55M | $60.00M | $38.44M | $51.00M |
| Total liabilities | $2.16M | $2.52M | $3.22M | $5.38M | $2.39M | $3.85M | $4.37M | $5.45M | $15.47M | $12.18M | $18.21M | $12.06M | $8.98M | $9.41M | $14.23M | $12.82M | $83.65M | $51.73M | $39.00M | $36.21M |
| Current liabilities | $706597.00 | $615648.00 | $1.46M | $3.38M | $1.16M | $2.48M | $3.15M | $4.39M | $6.96M | $7.13M | $12.46M | $8.85M | $6.88M | $6.81M | $6.49M | $7.77M | $47.12M | $18.98M | $17.96M | $13.98M |
| Long-term debt | — | — | — | — | — | — | — | — | — | $409271.00 | $4.97M | $1.15M | $18000.00 | — | — | — | — | — | — | — |
| Shareholder equity | $-196581.00 | $-1.87M | $-3.05M | $-4.35M | $7.05M | $38.17M | $28.65M | $9.58M | $14.80M | $36.46M | $26.89M | $117.93M | $162.64M | $93.84M | $112.96M | $96.20M | $92.22M | $73.34M | $63.42M | $78.38M |
| Retained earnings | $-40.54M | $-42.41M | $-43.84M | $-47.63M | $-52.77M | $-63.95M | $-80.47M | $-101.90M | $-145.78M | $-182.19M | $-229.18M | $-196.32M | $-216.30M | $-261.86M | $-273.42M | $-294.08M | $-337.10M | $-363.37M | $-384.86M | $-403.46M |
| Accounts receivable | — | — | — | — | $-138547.00 | — | — | — | $1.12M | $1.04M | $1.65M | $1.16M | $3.05M | $3.72M | $24.74M | $4000.00 | $50.84M | $297000.00 | $745000.00 | $638000.00 |
| Inventory | — | — | — | — | $38384.00 | $45470.00 | $51174.00 | $55316.00 | $178694.00 | $266022.00 | $1000.00 | — | $1.00 | $1.00 | $1.00 | — | — | $1.00 | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M |